SPOTLIGHT -
NCCN Update in Urothelial Bladder Cancer Highlights Checkpoint Inhibitors, Maintenance Therapy
The advent of checkpoint inhibitors has altered the treatment landscape in urothelial bladder cancer, said Arlene O. Siefker-Radtke, MD, during last week’s NCCN Conference.
Read More
